Skip to main content

Organigram Global Inc.

OGI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001620737

No open-market purchases or sales by Organigram Global Inc. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $7.87M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Organigram Global Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of OGI: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders8679−7
Shares11.3M5.78M−5.54M (−48.9%)
Value$24.3M$8.92M−$15.4M (−63.3%)

New holders (10)

Institutions that held Organigram Global Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to OGI in Q2 2024
InstitutionSharesValue% of portfolio
Clear Harbor Asset Management, LLC32,750$50.5K0.00%
Citadel Advisors LLC28,975$44.6K0.00%
State of Wyoming28,915$44.5K0.01%
Two Sigma Securities, LLC10,215$15.7K0.00%
Activest Wealth Management750$1.16K0.00%
Fifth Third Bancorp500$7700.00%
Farther Finance Advisors, LLC87$1340.00%
Coppell Advisory Solutions LLC15$230.00%
Triad Wealth Partners, LLC7$110.00%
CWM, LLC232$00.00%

Sold out (17)

Institutions that held Organigram Global Inc. at the end of Q1 2024 and filed for Q2 2024 without it.